Buffalo Grove, IL, United States of America

Beimar N Iriarte


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Beimar N Iriarte: Innovator in Steroid Immunoassay Standards

Introduction

Beimar N Iriarte is a notable inventor based in Buffalo Grove, IL (US). She has made significant contributions to the field of immunoassays, particularly in the stabilization of steroid compounds. Her innovative work has led to the development of a patented solution that addresses the challenges of oxidative degradation in steroid compounds.

Latest Patents

Iriarte holds a patent for "Stabilized aqueous steroid immunoassay standards with cyclodextrins." This patent describes aqueous solutions of steroid compounds that possess biological activity and are prone to oxidative degradation when stored at temperatures between 2°C and 8°C for extended periods. The addition of cyclodextrin serves to stabilize these compounds, enhancing their usability in various applications.

Career Highlights

Beimar N Iriarte is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. Her work at Abbott has allowed her to focus on innovative solutions that improve the reliability and effectiveness of immunoassays. With her expertise, she has contributed to advancements in the field that benefit both research and clinical applications.

Collaborations

Throughout her career, Iriarte has collaborated with esteemed colleagues, including Gregg T Williams and William R Groskopf. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Beimar N Iriarte's contributions to the field of steroid immunoassays exemplify her dedication to innovation and scientific advancement. Her patented work not only addresses critical challenges in the stabilization of steroid compounds but also enhances the overall effectiveness of immunoassays.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…